Pierre Sabouret: Exploring Impact of Lipoprotein(a) on Residual Cardiovascular Risk After an Acute Coronary Syndrome
Pierre Sabouret, Member of the Executive Committee for Education at European Atherosclerosis Society, shared a post on LinkedIn about a recent article he and his colleagues co-authored, adding:
“New publication available online with open access. Thanks to my friend and expert Francesco Costa for the invitation.
Congratulations to all coauthors for this achievement.”
Title: Impact of Lipoprotein(a) on Residual Cardiovascular Risk After an Acute Coronary Syndrome
Autors: Nelsa González-Aguado, Rafael Franco-Hita, Jose Ignacio Larrubia-Valle, Fernando Puyol-Ruiz, Ainhoa Robles-Mezcua, José Manuel García-Pinilla, María Jiménez-Salva, Alberto Piserra-López, Francisco Javier Pavon-Moron, Alejandro Pérez-Cabeza, Pierre Sabouret, Francesco Costa
Read the Full Article on Journal of Clinical Medicine.
Stay updated on all scientific advances with Hemostasis Today.
-
Feb 28, 2026, 16:25Akshat Jain: Elevating Equity in Diagnosis, Care, and Research on World Rare Disease Day 2026
-
Feb 28, 2026, 16:21Inaugural CLL and Lymphoma EU Focus Meeting 2026 Earns CME Credites – MD Education
-
Feb 28, 2026, 16:16Michael Makris: Lower Doses of Hemlibra May Still Be Effective
-
Feb 28, 2026, 16:10Matías J Alet: An Age-Related Etiologic Shift for Young Stroke In Uruguay
-
Feb 28, 2026, 16:03Alia Alghwiri: Patient Education to Improve Quality of Life of Stroke Survivors
-
Feb 28, 2026, 15:46Shreya Agrawal: Integrated Risk Scores for Thrombosis and Bleeding
-
Feb 28, 2026, 15:02Stéphanie Forté: Advancing Stroke Prevention in Adults With Sickle Cell Disease Through Transcranial Doppler
-
Feb 28, 2026, 14:52Jonathan Douxfils: Are All Progestin-Only Contraceptives Truly ‘Neutral’ for VTE Risk?
-
Feb 28, 2026, 14:48WFH Acknowledges BioMarin’s Decision to Discontinue ROCTAVIAN